Aphena welcomes Prokopczyk as VP of Quality and Regulatory Affairs

COOKEVILLE — Aphena Pharma Solutions is proud to announce the addition of Matthew Prokopczyk to its quality leadership team as vice president of quality and regulatory affairs.  

Prokopczyk joined Aphena in July 2020 and brings 25 years of experience in the pharmaceutical industry in the areas of quality control, regulatory compliance and quality assurance. Prior to joining Aphena, Prokopczyk was vice president of global quality at Amerigen Pharmaceuticals. His earlier experience includes positions as vice president of U.S. quality at Alvogen; senior director of quality at Dr. Reddy’s Laboratories and earlier roles in quality at IVAX Pharmaceuticals (currently Teva), Purdue Pharma and Wyeth (currently Pfizer). Prokopczyk has an undergraduate degree in biology from the College of Mount St. Vincent and an MBA from Fordham University.

“We are excited to have Matthew join the Aphena leadership team,” said Aphena CEO Shawn Reilley. “He is a talented quality executive with broad QRA leadership experience in the cGMP manufacturing and packaging segments of the pharmaceutical industry. Matthew is sure to elevate Aphena’s performance and compliance across our business and our customer base.”

Aphena Pharma Solutions is an industry-leading organization providing contract manufacturing and packaging services for the biologics, pharmaceutical, consumer health and medical device markets. With two separate FDA- and DEA-registered locations in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotion-based products.

For more information about Aphena, visit www.aphenapharma.com or call (931) 372-2041. 

This site uses Akismet to reduce spam. Learn how your comment data is processed.